Superior Vena Cava Syndrome Induced by Endocardial Defibrillator and Pacemaker Leads

Arash Aryana, Kristi D. Sobota, Dennis J. Esterbrooks, Andrew I. Gelbman

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Two cases of superior vena cava syndrome induced by endocardial defibrillator and pacemaker leads are described. The 2 patients had histories of multiple endocardial leads and device upgrades and venous thrombosis. The first patient was treated with laser lead extraction followed by percutaneous venoplasty and stenting. The second patient was treated conservatively with long-term anticoagulation. The 2 patients had symptomatic reduction. In conclusion, superior vena cava syndrome induced by transvenous leads is an uncommon but serious complication. Anticoagulation can be effective in select patients, but in severe cases, thrombolytic therapy or surgical or percutaneous intervention may be required.

Original languageEnglish
Pages (from-to)1765-1767
Number of pages3
JournalAmerican Journal of Cardiology
Volume99
Issue number12
DOIs
StatePublished - Jun 15 2007

Fingerprint

Superior Vena Cava Syndrome
Defibrillators
Thrombolytic Therapy
Venous Thrombosis
Lasers
Equipment and Supplies

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine

Cite this

Superior Vena Cava Syndrome Induced by Endocardial Defibrillator and Pacemaker Leads. / Aryana, Arash; Sobota, Kristi D.; Esterbrooks, Dennis J.; Gelbman, Andrew I.

In: American Journal of Cardiology, Vol. 99, No. 12, 15.06.2007, p. 1765-1767.

Research output: Contribution to journalArticle

Aryana, Arash ; Sobota, Kristi D. ; Esterbrooks, Dennis J. ; Gelbman, Andrew I. / Superior Vena Cava Syndrome Induced by Endocardial Defibrillator and Pacemaker Leads. In: American Journal of Cardiology. 2007 ; Vol. 99, No. 12. pp. 1765-1767.
@article{4de4c807fc394b4b9c925d347e0cfa43,
title = "Superior Vena Cava Syndrome Induced by Endocardial Defibrillator and Pacemaker Leads",
abstract = "Two cases of superior vena cava syndrome induced by endocardial defibrillator and pacemaker leads are described. The 2 patients had histories of multiple endocardial leads and device upgrades and venous thrombosis. The first patient was treated with laser lead extraction followed by percutaneous venoplasty and stenting. The second patient was treated conservatively with long-term anticoagulation. The 2 patients had symptomatic reduction. In conclusion, superior vena cava syndrome induced by transvenous leads is an uncommon but serious complication. Anticoagulation can be effective in select patients, but in severe cases, thrombolytic therapy or surgical or percutaneous intervention may be required.",
author = "Arash Aryana and Sobota, {Kristi D.} and Esterbrooks, {Dennis J.} and Gelbman, {Andrew I.}",
year = "2007",
month = "6",
day = "15",
doi = "10.1016/j.amjcard.2007.01.065",
language = "English",
volume = "99",
pages = "1765--1767",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "12",

}

TY - JOUR

T1 - Superior Vena Cava Syndrome Induced by Endocardial Defibrillator and Pacemaker Leads

AU - Aryana, Arash

AU - Sobota, Kristi D.

AU - Esterbrooks, Dennis J.

AU - Gelbman, Andrew I.

PY - 2007/6/15

Y1 - 2007/6/15

N2 - Two cases of superior vena cava syndrome induced by endocardial defibrillator and pacemaker leads are described. The 2 patients had histories of multiple endocardial leads and device upgrades and venous thrombosis. The first patient was treated with laser lead extraction followed by percutaneous venoplasty and stenting. The second patient was treated conservatively with long-term anticoagulation. The 2 patients had symptomatic reduction. In conclusion, superior vena cava syndrome induced by transvenous leads is an uncommon but serious complication. Anticoagulation can be effective in select patients, but in severe cases, thrombolytic therapy or surgical or percutaneous intervention may be required.

AB - Two cases of superior vena cava syndrome induced by endocardial defibrillator and pacemaker leads are described. The 2 patients had histories of multiple endocardial leads and device upgrades and venous thrombosis. The first patient was treated with laser lead extraction followed by percutaneous venoplasty and stenting. The second patient was treated conservatively with long-term anticoagulation. The 2 patients had symptomatic reduction. In conclusion, superior vena cava syndrome induced by transvenous leads is an uncommon but serious complication. Anticoagulation can be effective in select patients, but in severe cases, thrombolytic therapy or surgical or percutaneous intervention may be required.

UR - http://www.scopus.com/inward/record.url?scp=34249906996&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34249906996&partnerID=8YFLogxK

U2 - 10.1016/j.amjcard.2007.01.065

DO - 10.1016/j.amjcard.2007.01.065

M3 - Article

VL - 99

SP - 1765

EP - 1767

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 12

ER -